The disease is characterized by synaptic loss, dendritic spine reduction, and altered glutamate receptor-dependent pathways, unveiling the intricate interplay between Aβ, Tau, and synaptic dysfunction in the pathogenesis of AD. The gene discussed is MAPT; the disease is Alzheimer disease.